Staff Reports
A new CDC‑authored analysis in the journal Medical Care drops a number big enough to make Washington pay attention: chronic pain costs the United States about $722.8 billion a year. That’s $530.6 billion in medical care and $192.2 billion in lost work productivity. The study is a reminder that we are spending vast sums while too many Americans still can’t get real, lasting help for chronic pain.
The price tag that won’t be ignored
The study, led by CDC researchers including Gery P. Guy Jr. of the Division of Overdose Prevention, used national Medical Expenditure Panel Survey data and found that adults with chronic pain incur roughly $8,068 more a year in medical bills and $2,923 more in lost productivity than people without chronic pain. The authors identified about 65.8 million adults with chronic pain in the sample and used careful regression methods to estimate excess costs. Even with some populations left out, the bottom line is clear: chronic pain is a massive economic and human problem.
So why do we spend so much and get so little?
Access and policy failures, plain and simple
Here’s the unpleasant truth: most of that $722.8 billion buys paperwork, delays, and fragmented care more often than it buys relief. Research shows nonpharmacologic and multidisciplinary treatments — physical therapy, behavioral pain care, coordinated programs — are underused because insurers limit coverage, require prior authorization, or simply don’t have enough providers in rural areas. At the same time, misapplied opioid‑prescribing rules in past years harmed patients who needed stable treatment. The CDC’s 2022 guideline urges multimodal, patient‑centered care, yet real‑world access lags behind the guidance. So we pay more and suffer more — a bad deal for taxpayers and patients alike.
What policymakers and insurers should stop doing — and start doing
Washington loves a headline and a regulation, but chronic pain needs better policy, not more theater. Start by restoring clinician judgment: federal guidance should be a floor, not a cudgel that forces rapid tapers or abandons patients. Insurers should eliminate needless prior authorization for proven therapies, expand coverage for nonpharmacologic care, and fund multidisciplinary pain programs that return people to work. Rural areas need telehealth and incentives for pain specialists. And yes, accountability matters: if hundreds of billions are being spent, show results — not just processed claims.
Conclusion: fix care, or keep paying for failure
The $722.8 billion figure should be a wake‑up call. Chronic pain is not a budget line to be shuffled; it’s millions of Americans losing sleep, jobs, and time with family. Lawmakers, regulators, and insurers can keep pretending high spending equals quality care — or they can address the real bottlenecks: coverage rules, provider shortages, and one‑size‑fits‑all policies that ignore patient needs. If we want better outcomes, stop counting costs like accountants and start fixing care like clinicians. Otherwise, we’ll keep paying more for less — and that’s a conservative and liberal failure alike.
